摘要
经皮冠状动脉介入术(Percutaneous Coronary Intervention,PCI)是ST段抬高型心肌梗死(ST-segment Elevation Myocardial Infarction,STEMI)患者首选的再灌注策略。然而,尽管心外膜血流已恢复,但由于微血管阻塞的发生,PCI术后可出现“无复流”(No-flow Phenomemon,NR)现象,这种现象与不良心室重塑、心力衰竭和恶性心律失常、死亡等不良临床事件密切相关。NR的发病机制复杂,目前尚无成熟、标准的治疗策略。本文从NR的中西医发病机制、治疗策略等方面展开综述,以期为防治NR的深入研究提供新思路。
Percutaneous coronary intervention(PCI)is the first choice of reperfusion strategy for patients with ST segment elevation myocardial infarction(STEMI).However,although epicardial blood flow has recovered,“Non-reflow”may occur after PCI due to microvascular occlusion.This phenomenon is closely related to adverse clinical events such as adverse ventricular remodeling,heart failure,malignant arrhythmia and death.The incidence of NR is complex,and there is no mature and standard treatment strategy at present.This article reviews the pathogenesis and treatment strategies of NR in traditional Chinese and western medicine in order to provide new ideas for the further study of prevention and treatment of NR.
作者
周虹
杨洁连
梁珊
ZHOU Hong;YANG Jielian;LIANG Shan
出处
《中医临床研究》
2021年第30期62-65,共4页
Clinical Journal Of Chinese Medicine
关键词
无复流
经皮冠状动脉介入术
ST段抬高型心肌梗死
中医药
Non-reflow
Percutaneous coronary intervention
ST-segment elevation myocardial infarction
Traditional Chinese medicine
